Your browser doesn't support javascript.
loading
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group.
Lapierre, Ariane; Hennequin, Christophe; Beneux, Amandine; Belhomme, Sarah; Benziane Ouaritini, Nicolas; Biston, Marie-Claude; Crehange, Gilles; de Crevoisier, Renaud; Dumas, Jean-Luc; Fawzi, Maher; Lisbona, Albert; Pasquier, David; Pelissier, Sandra; Graff-Cailleaud, Pierre; Pommier, Pascal; Sargos, Paul; Simon, Jean-Marc; Supiot, Stéphane; Tantot, Florence; Chapet, Olivier.
Affiliation
  • Lapierre A; Département of de radiothérapie oncologie, centre hospitalier universitaire Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France; Université de Lyon, 69000 Lyon, France.
  • Hennequin C; Department of Radiation Oncology, Hôpital Saint-Louis, 75475 Paris, France.
  • Beneux A; Service de Physique Médicale et de Radioprotection, centre hospitalier universitaire Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France.
  • Belhomme S; Radiation Oncology Department, Bergonie Institute, 229, cours de l'Argonne, 33076 Bordeaux Cedex, France.
  • Benziane Ouaritini N; Radiation Oncology Department, Bergonie Institute, 229, cours de l'Argonne, 33076 Bordeaux Cedex, France. Electronic address: Nicolasbenziane@hotmail.fr.
  • Biston MC; Léon Bérard Cancer Center, University of Lyon, France; Université de Lyon, CREATIS, CNRS UMR5220, Inserm, U1044 INSA, Lyon, France.
  • Crehange G; Département de radiothérapie oncologique, institut Curie, 26, rue d'Ulm, 75005 Paris, France.
  • de Crevoisier R; Département de Radiothérapie, Centre Eugène Marquis, Rennes, France.
  • Dumas JL; Institut Curie, Radiotherapy department / Medical physics, 26 rue d'Ulm, 75005 cedex Paris, France.
  • Fawzi M; Institut Curie, Site Saint Cloud, Service de Radiotherapie, 35, rue Dailly, 92210 Saint Cloud, France.
  • Lisbona A; Medical Physics Department Institut de Cancérologie de l'Ouest, Bd J. Monod, 44805 Saint Herblain, France.
  • Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille; CRIStAL UMR, 9189 Lille, France.
  • Pelissier S; GETUG Group, Unicancer, Paris, France.
  • Graff-Cailleaud P; University Institute of Cancer Toulouse-Oncopôle, Toulouse, France.
  • Pommier P; Radiotherapy Department, Centre Léon Bérard, Lyon, France.
  • Sargos P; Radiation Oncology Department, Bergonie Institute, Bordeaux, France.
  • Simon JM; Department of Radiotherapy, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France.
  • Supiot S; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, St-Herblain, France.
  • Tantot F; GETUG Group, Unicancer, Paris, France.
  • Chapet O; Département of de radiothérapie oncologie, centre hospitalier universitaire Lyon Sud, 165, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France; Université de Lyon, 69000 Lyon, France. Electronic address: olivier.chapet@chu-lyon.fr.
Crit Rev Oncol Hematol ; 173: 103661, 2022 May.
Article in En | MEDLINE | ID: mdl-35341986
Stereotactic body radiotherapy (SBRT) has become treatment option for localized prostate cancer but the evidence base remains incomplete. Several clinical studies, both prospective and retrospective, have been published. However, treatment techniques, target volumes and dose constraints lack consistency between studies. Based on the current available literature, the French Genito-Urinary Group (GETUG) suggests that.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Radiosurgery Type of study: Observational_studies Limits: Humans / Male Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Radiosurgery Type of study: Observational_studies Limits: Humans / Male Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Type: Article Affiliation country: France